Works by Zhu, Yejiang

Results: 4
    1

    Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 14, p. 6195, doi. 10.1002/cam4.2399
    By:
    • Zhu, Feng‐Cai;
    • Hu, Shang‐Ying;
    • Hong, Ying;
    • Hu, Yue‐Mei;
    • Zhang, Xun;
    • Zhang, Yi‐Ju;
    • Pan, Qin‐Jing;
    • Zhang, Wen‐Hua;
    • Zhao, Fang‐Hui;
    • Zhang, Cheng‐Fu;
    • Yang, Xiaoping;
    • Yu, Jia‐Xi;
    • Zhu, Jiahong;
    • Zhu, Yejiang;
    • Chen, Feng;
    • Zhang, Qian;
    • Wang, Hong;
    • Wang, Changrong;
    • Bi, Jun;
    • Xue, Shiyin
    Publication type:
    Article
    2

    Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trial.

    Published in:
    Cancer Medicine, 2017, v. 6, n. 1, p. 12, doi. 10.1002/cam4.869
    By:
    • Zhu, Feng‐cai;
    • Hu, Shang‐Ying;
    • Hong, Ying;
    • Hu, Yue‐Mei;
    • Zhang, Xun;
    • Zhang, Yi‐Ju;
    • Pan, Qin‐Jing;
    • Zhang, Wen‐Hua;
    • Zhao, Fang‐Hui;
    • Zhang, Cheng‐Fu;
    • Yang, Xiaoping;
    • Yu, Jia‐Xi;
    • Zhu, Jiahong;
    • Zhu, Yejiang;
    • Chen, Feng;
    • Zhang, Qian;
    • Wang, Hong;
    • Wang, Changrong;
    • Bi, Jun;
    • Xue, Shiyin
    Publication type:
    Article
    3

    Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial.

    Published in:
    Human Vaccines & Immunotherapeutics, 2021, v. 17, n. 4, p. 955, doi. 10.1080/21645515.2020.1829411
    By:
    • Hu, Shangying;
    • Xu, Xiaoqian;
    • Zhu, Fengcai;
    • Hong, Ying;
    • Hu, Yuemei;
    • Zhang, Xun;
    • Pan, Qinjing;
    • Zhang, Wenhua;
    • Zhang, Chengfu;
    • Yang, Xiaoping;
    • Yu, Jiaxi;
    • Zhu, Jiahong;
    • Zhu, Yejiang;
    • Chen, Feng;
    • Zhao, Shuang;
    • Karkada, Naveen;
    • Tang, Haiwen;
    • Bi, Dan;
    • Struyf, Frank;
    • Zhao, Fanghui
    Publication type:
    Article
    4

    Safety of AS04‐HPV‐16/18 vaccine in Chinese women aged 26 years and older and long‐term protective effect in women vaccinated at age 18–25 years: A 10‐year follow‐up study.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 4, p. 458, doi. 10.1111/ajco.13833
    By:
    • Zhao, Fanghui;
    • Jastorff, Archana;
    • Hong, Ying;
    • Hu, Shangying;
    • Chen, Wen;
    • Xu, Xiaoqian;
    • Zhu, Yejiang;
    • Zhu, Jiahong;
    • Zhang, Xun;
    • Zhang, Wenhua;
    • Xu, Dacheng;
    • Wang, Dali;
    • Tang, Rong;
    • Sun, Yonghong;
    • Shen, Yiping;
    • Pan, Qinjing;
    • Yin, Jian;
    • Liu, Daokuan;
    • Liu, Bin;
    • Karkada, Naveen
    Publication type:
    Article